Neptune tackles dyslipidemia in risk-benefit analysis

By staff reporter

- Last updated on GMT

Related tags Cholesterol Atherosclerosis

Neptune Technologies & Bioressources is undertaking a
population-based risk-benefit analysis for its proprietary Neptune
krill oil (NKO) and the management of dyslipidemia.

NKO is derived from the planktonic family of crustaceans and, like omega-3, is rich in phospholipids and antioxidants. Dyslipidemia is the elevation of lipids in the blood. It is associated with increased "bad" low-density lipoprotein (LDL) cholesterol and a decreased "good" high-density lipoprotein (HDL) cholesterol.

The Canadian manufacturer expects the study to demonstrate a low risk-benefit ratio for NKO that facilitates risk management for patients with dyslipidemia, with an eye to playing a role in heart disease prevention.

Managing dyslipidemia is linked to preventing cardiovascular disease. Low levels of HDL cholesterol present a risk factor for cardiovascular disease. Therefore, according to Neptune, treatments that reduce LDL and increase HDL are much more effective in preventing cardiovascular disease when compared to those that only reduce LDL.

"Unfortunately recently developed products that achieve both HDL increase and LDL reduction have been associated with a significant risk for serious side effects and hence are not appropriate for use by humans due to safety concerns,"​said Dr. Tina Sampalis, vice-president R&D and business development at Neptune. "The risk-benefit ratio for these treatments is too high to support their approval and use in the long-term care."

NKO was first launched to the US dietary supplements market in 2003, but company has not yet emerged from the commercialization stage into profitability. Nonetheless, the signals are positive and it seems more and more people are getting know about NKO.

Neptune uses a cold-processing technological platform to extract an oil from krill (a planktonic family of crustaceans), that is loaded with omega-3 fatty acids, phospholipids and antioxidants. It also offers a marine protein concentrate called Neptune Krill Aquatein that boasts over 80 per cent purity and contains a mix of amino acids, digestive enzymes, and peptides.

"We have repeatedly demonstrated the safety of NKO for chronic use and we are confident that these analyses will further validate our findings,"​ said Dr. Sampalis.

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 18-Jun-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Ride the next wave of omega-3 innovation

Ride the next wave of omega-3 innovation

Content provided by dsm-firmenich | 01-Jun-2024 | Insight Guide

Fish oil supplies can’t scale to meet the needs of the planet’s growing population, but life’s®OMEGA can.

Related suppliers

Follow us


View more